Survivor Treatment Selection Bias in Evaluations of Virtual Transition of Care - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Bias in Treatment Selection Among Survivors in Assessments of Virtual Care Transition

  • By

  • Hongmei Yang

  • Christopher D Russell

  • Amy Arnder Greene

  • Angela D Humphrey

  • September 10, 2026

Share

Clinical Scorecard: Bias in Treatment Selection Among Survivors in Assessments of Virtual Care Transition

At a Glance

CategoryDetail
ConditionVirtual Transition of Care Clinics
Key MechanismsSurvivor treatment selection bias and immortal time bias affect outcome evaluation.
Target PopulationPatients undergoing virtual transition of care follow-up after hospitalization.
Care SettingPost-discharge virtual care settings.

Key Highlights

  • VToC follow-up associated with lower 30-day readmission rates.
  • Survivor treatment selection bias may overestimate readmission rates in non-VToC groups.
  • Intent-to-treat analysis recommended to mitigate bias.
  • Temporal concordance is crucial in assessing exposure and outcomes.
  • Adjustment for baseline risk factors alone cannot eliminate bias.

Guideline-Based Recommendations

Diagnosis

    Management

    • Use intent-to-treat analysis using referral status.
    • Incorporate time-varying Cox regression models to address exposure timing.

    Monitoring & Follow-up

      Risks

      • Risk of misclassification of patients experiencing early readmission.

      Patient & Prescribing Data

      Patients discharged from hospitalization requiring follow-up care.

      Completion of virtual follow-up visits may not correlate with reduced readmissions due to bias.

      Clinical Best Practices

      • Address exposure timing explicitly in analyses.
      • Evaluate the impact of survivor treatment selection bias in observational studies.

      Related Resources & Content

      Original Source(s)

      Related Content